Aug 8, 2019

Young blood cocktail stops Alzheimer’s decline, early clinical trial reports

Posted by in categories: biotech/medical, neuroscience

Alkahest, a California-based biotech start-up, has just revealed some compelling early results from an ongoing Phase 2 trial into the efficacy of its novel formulation of plasma proteins derived from young blood, developed to slow, or even stop, the cognitive decline associated with Alzheimer’s disease.

Leave a reply